| __timestamp | Bio-Techne Corporation | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60716000 | 9335772 |
| Thursday, January 1, 2015 | 119401000 | 12390000 |
| Friday, January 1, 2016 | 140879000 | 25602000 |
| Sunday, January 1, 2017 | 199243000 | 21262000 |
| Monday, January 1, 2018 | 240636000 | 28430000 |
| Tuesday, January 1, 2019 | 264359000 | 40849000 |
| Wednesday, January 1, 2020 | 260583000 | 60210000 |
| Friday, January 1, 2021 | 324951000 | 83664000 |
| Saturday, January 1, 2022 | 372766000 | 104097000 |
| Sunday, January 1, 2023 | 378378000 | 106916000 |
| Monday, January 1, 2024 | 396826000 |
Cracking the code
In the dynamic world of biotechnology, understanding financial trends is crucial for investors and stakeholders. This analysis focuses on the Selling, General, and Administrative (SG&A) expenses of two prominent companies: Bio-Techne Corporation and Iovance Biotherapeutics, Inc., from 2014 to 2023.
Bio-Techne Corporation has shown a consistent upward trend in SG&A expenses, increasing by over 550% from 2014 to 2023. This growth reflects the company's expanding operations and strategic investments in research and development. In contrast, Iovance Biotherapeutics, Inc. experienced a staggering 1,045% increase in SG&A expenses over the same period, highlighting its aggressive growth strategy and market expansion efforts.
While Bio-Techne's expenses peaked in 2024, Iovance's data for 2024 is unavailable, indicating potential volatility or strategic shifts. These insights provide a window into the financial health and strategic priorities of these biotech giants.
Breaking Down SG&A Expenses: AstraZeneca PLC vs Iovance Biotherapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
United Therapeutics Corporation and Bio-Techne Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Iovance Biotherapeutics, Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Bio-Techne Corporation and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
Comparing SG&A Expenses: Bio-Techne Corporation vs Corcept Therapeutics Incorporated Trends and Insights
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.
Cost Management Insights: SG&A Expenses for Apellis Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?